• Home
  • About MSG
  • Membership
  • Clinical Trials
  • Fellowship
  • Publications
  • Resources
    • Resources
    • Upcoming Neuromuscular Meetings
  • MSG Meetings
    • 2021 Muscle Study Group Annual Scientific Meeting
    • Meetings Archive
Skip to content

Muscle Study Group

  • Log In
  • Register
  • Home
  • About MSG
  • Membership
  • Clinical Trials
  • Fellowship
  • Publications
  • Resources
    • Resources
    • Upcoming Neuromuscular Meetings
  • MSG Meetings
    • 2021 Muscle Study Group Annual Scientific Meeting
    • Meetings Archive
msg-admin

Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis

Posted on April 7, 2016 by msg-admin

This study is active but not currently enrolling participants.

This entry was posted in MSG Studies, Terminated. Bookmark the permalink.

Clinical Trials

  • Investigating Pompe Prevalence in Neuromuscular Medicine Academic Practices (IPANEMA)
  • Natural History Study of Spinal Muscular Atrophy (SMA)
  • Ascorbic Acid Treatment of Charco-Marie Tooth Type 1A (CMT)
  • Dichlorphenamide vs. Placebo for the Treatment of Patients with Hyperkalemic or Hypokalemic Periodic Paralysis (HYP-HOP)
  • Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME)
  • Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis (MG-SCIg)
  • Methotrexate in Myasthenia Gravis (Methotrexate)
  • Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis
  • Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis (Rasagiline)
  • Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find the Optimum Steroid Regimen (FOR-DMD)
  • Arimoclomol in Sporadic Inclusion Body Myositis (Arimoclomol)
  • The International IBM Consortium Genetic Study

Contact Us

Elizabeth Russo Paulk
Muscle Study Group

Privacy Policy

Site Search

Join the Muscle Study Group

© The Muscle Study Group Inc. All rights reserved. Site by Academic Web Pages

Back to Top